It's #InternationalBrainTumourAwareness Week - and did you know that Brain Tumour Related #Epilepsy (#BTRE) affects 30-40% of people with a brain tumour?! Raise awareness of brain tumours and their impacts this week! epilepsysparks.com/october/intern… Check out our podcasts re BTRE with:

Getting ready for the art festival celebrating survivors, just as the festivities approach. Happy Diwali to all!

The All.Can Global Summit event report is now available! Read for expert insights into ways, and concrete recommendations, to build better and more #efficientcancercare around the world. Read the full report 👇 lnkd.in/e6cskSf4

Pediatric brain tumours are rare but the outcome for the child and their family is devastating #IBTAWeek

Glioblastomas almost always recur after standard treatments. Better treatments are desperately needed #IBTAWeek

After one conference ends, another begins! 🎉 #EANO2025 will take place in beautiful Prague🇨🇿 from October 16-19, 2025. Join us to deepen your #NeuroOncology expertise, connect with experts, and share your work with the community. See you in #Prague! eano.eu/eano2025/ #btsm

Read these short summaries of amazing research articles published in Editor - Neuro-Oncology Advances We are committed to making brain tumor research #accessible and #inclusive to a broad audience! Find these online for upcoming original clinical or basic & translational research articles!

📢 Next week we'll unveil the new #CancerWorkforce report. Cancer care professionals across Europe are struggling with staff shortages, expanding bureaucracy, burnout, and more. It's taking a huge toll on their work and the quality of treatment they provide to #Patients. 💬

Pediatric brain tumors can be especially daunting. That’s why we’re proud to have supported 95 pediatric families last year with individualized guidance and care. Together, we’re making a difference for the next generation. ow.ly/8Wox50UQmhn

🎗️ Today is #WorldCancerDay – a reminder of the ongoing fight against cancer and the need for research, collaboration & innovation in all types, including #NeuroOncology. At #EANO, we’re dedicated to advancing science & patient care. Together, we can make a difference! 💙

Today is World Cancer Day! 🗓️ In the lead up to #RareDiseaseDay 2025, help us to spread awareness about the unique challenges facing the 5.1 million people who are living with a rare cancer in Europe! ➡️ Learn more: go.eurordis.org/RareCancers

In the UK, nearly 1 in 2 people will get cancer in their lifetime. It's World Cancer Day today – a global day to raise awareness and take action against cancer 🌍 Whatever your cancer experience, or however you’ve supported our work in the past, share this post and help us get

After years of dedicated research, we are excited to officially launch the results of SISAQOL-IMI! 🔬 This milestone marks a significant step toward improving patient-centred research and ensuring high-quality PRO data in clinical studies. Subscribe: sisaqol-imi.org

If you've been impacted by GBM, please consider signing up to our focus group on the new and exciting PREDICT research study on Feb 19th at 3pm, as your knowledge and lived experience would be invaluable to the design of this project. Sign up here: buff.ly/4jEdlLt..

Visit our website gliomaregistry.org for details in both English and Spanish and to learn about low grade glioma in general Low Grade Glioma Registry American Brain Tumor Association National Brain Tumor Society Salud America! IBTA Yale School of Public Health

🌍 On #WorldCancerDay, we unite with organizations worldwide to advance research, raise awareness, and bring hope to those impacted by cancer. Together, we can end cancer forever. 💙 #EndCancer #HopeAndHealing

On #WorldCancerDay, we honor the profound personal impact of cancer. With 1 in 5 people worldwide facing a cancer diagnosis, access to proper treatment is crucial. Brain Tumor Network is dedicated to supporting those affected by brain cancer. Discover more at: bit.ly/3Bg4oTG

This study, featured in our latest issue, showed that specific features and genetic markers of #IDHMutant #gliomas were linked to less successful #tumor removal. Using this data, the authors of the study developed an online calculator for clinical use. bit.ly/3X50Tef

The #EUCancerPlan has been a success for member states, yet so much remains to be done. 👈 Inequalities in reach and accessibility of cancer care persist. The solution: concrete, data-driven insights to drive robust policy action. 📈 The #EuropeanCancerPulse provides vital